Emergent Biosolutions Stock Analysis

Emergent Stock Analysis Notes

About 58.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Emergent Biosolutions has Price/Earnings To Growth (PEG) ratio of 1.55. The entity recorded a loss per share of 11.22. The firm had not issued any dividends in recent years. Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats in the United States. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. Emergent Biosolutions operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 2416 people. To learn more about Emergent Biosolutions call Joseph Papa at 240 631 3200 or check out https://www.emergentbiosolutions.com.

Emergent Biosolutions Investment Alerts

Emergent Biosolutions Upcoming and Recent Events

Emergent Largest EPS Surprises

View All Earnings Estimates

Emergent Biosolutions Environmental, Social, and Governance (ESG) Scores

Emergent Stock Institutional Investors

Note, although Emergent Biosolutions' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Emergent Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 540.22 M.

Emergent Profitablity

The company has Net Profit Margin of (0.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.25 %, which entails that for every 100 dollars of revenue, it generated $0.25 of operating income.

Management Efficiency

Emergent Biosolutions has Return on Asset of (0.0422) % which means that on every $100 spent on assets, it lost $0.0422. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3464) %, meaning that it generated no profit with money invested by stockholders. Emergent Biosolutions' management efficiency ratios could be used to measure how well Emergent Biosolutions manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.2 in 2025. Return On Capital Employed is likely to gain to -0.08 in 2025. At this time, Emergent Biosolutions' Non Current Assets Total are comparatively stable compared to the past year. Other Assets is likely to gain to about 231 M in 2025, whereas Non Currrent Assets Other are likely to drop slightly above 18 M in 2025.

Technical Drivers

As of the 25th of March, Emergent Biosolutions shows the Mean Deviation of 3.28, variance of 20.62, and Standard Deviation of 4.54. Emergent Biosolutions technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm Emergent Biosolutions mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Emergent Biosolutions is priced favorably, providing market reflects its regular price of 5.5 per share. Given that Emergent Biosolutions has information ratio of (0.12), we urge you to verify Emergent Biosolutions's prevailing market performance to make sure the company can sustain itself at a future point.

Emergent Biosolutions Price Movement Analysis

Emergent Biosolutions Insider Trading Activities

Emergent Biosolutions Outstanding Bonds

Emergent Biosolutions Predictive Daily Indicators

Emergent Biosolutions Corporate Filings

Emergent Biosolutions Forecast Models

Emergent Biosolutions' time-series forecasting models are one of many Emergent Biosolutions' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Emergent Biosolutions' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Emergent Biosolutions prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Emergent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Emergent Biosolutions. By using and applying Emergent Stock analysis, traders can create a robust methodology for identifying Emergent entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Emergent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Emergent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Emergent Biosolutions stock analysis indicators help investors evaluate how Emergent Biosolutions stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Emergent Biosolutions shares will generate the highest return on investment. By understating and applying Emergent Biosolutions stock analysis, traders can identify Emergent Biosolutions position entry and exit signals to maximize returns.

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.